HEARTBEAM INC (BEAT)

US42238H1086 - Common Stock

1.41  -0.01 (-0.7%)

Fundamental Rating

3

Overall BEAT gets a fundamental rating of 3 out of 10. We evaluated BEAT against 197 industry peers in the Health Care Equipment & Supplies industry. BEAT has a great financial health rating, but its profitability evaluates not so good. BEAT does not seem to be growing, but still is valued expensively.



0

1. Profitability

1.1 Basic Checks

In the past year BEAT has reported negative net income.
In the past year BEAT has reported a negative cash flow from operations.
BEAT had negative earnings in 4 of the past 5 years.
BEAT had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

BEAT has a Return On Assets of -73.65%. This is in the lower half of the industry: BEAT underperforms 78.57% of its industry peers.
BEAT has a worse Return On Equity (-77.67%) than 65.31% of its industry peers.
Industry RankSector Rank
ROA -73.65%
ROE -77.67%
ROIC N/A
ROA(3y)-830.81%
ROA(5y)-1577.03%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

BEAT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

9

2. Health

2.1 Basic Checks

Compared to 1 year ago, BEAT has more shares outstanding
Compared to 5 years ago, BEAT has less shares outstanding
There is no outstanding debt for BEAT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

BEAT has an Altman-Z score of 18.28. This indicates that BEAT is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 18.28, BEAT belongs to the best of the industry, outperforming 93.88% of the companies in the same industry.
BEAT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 18.28
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 19.12 indicates that BEAT has no problem at all paying its short term obligations.
With an excellent Current ratio value of 19.12, BEAT belongs to the best of the industry, outperforming 99.49% of the companies in the same industry.
A Quick Ratio of 19.12 indicates that BEAT has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 19.12, BEAT belongs to the best of the industry, outperforming 99.49% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 19.12
Quick Ratio 19.12

1

3. Growth

3.1 Past

BEAT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.78%, which is quite good.
EPS 1Y (TTM)10.78%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q70.45%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Revenue growth Q2QN/A

3.2 Future

The Earnings Per Share is expected to grow by 15.67% on average over the next years. This is quite good.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y54.67%
EPS Next 2Y28.18%
EPS Next 3Y15.67%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BEAT. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BEAT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as BEAT's earnings are expected to grow with 15.67% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y28.18%
EPS Next 3Y15.67%

0

5. Dividend

5.1 Amount

No dividends for BEAT!.
Industry RankSector Rank
Dividend Yield N/A

HEARTBEAM INC

NASDAQ:BEAT (2/27/2024, 10:09:09 AM)

1.41

-0.01 (-0.7%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap37.13M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -73.65%
ROE -77.67%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 19.12
Quick Ratio 19.12
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)10.78%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y54.67%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y